5 employees
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric surgery.
2019
AltrixBio Inc. raised undisclosed on January 1, 2021
Investors: XFactor Ventures, Walnut Ventures and Flybridge